(Q51365749)

4 April 2018

title

Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status. (English)

1 reference

4 April 2018

0 references

9

Toshifumi Hibi

1 reference

4 April 2018

author name string

Hiroshi Kishikawa

1

1 reference

4 April 2018

Jiro Nishida

2

1 reference

4 April 2018

Hitoshi Ichikawa

3

1 reference

4 April 2018

Shogo Kaida

4

1 reference

4 April 2018

Sakiko Takarabe

5

1 reference

4 April 2018

Takashi Matsukubo

6

1 reference

4 April 2018

Soichiro Miura

7

1 reference

4 April 2018

Tetsuo Morishita

8

1 reference

4 April 2018

publication date

1 December 2011

1 reference

4 April 2018

published in

Helicobacter

1 reference

4 April 2018

volume

16

1 reference

4 April 2018

issue

6

1 reference

4 April 2018

page(s)

427-433

1 reference

4 April 2018

Helicobacter pylori infection and the development of gastric cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in São Paulo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Seroconversion for Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Antral atrophy, Helicobacter pylori colonization, and gastric pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Serum nitrate/nitrite concentration correlates with gastric juice nitrate/nitrite: a possible marker for mutagenesis of the proximal stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Usefulness of gastric cancer screening using the serum pepsinogen test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Agreement between endoscopic and histological gastric atrophy scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

The selection of ELISA cut-off points for testing antibody to Newcastle disease by two-graph receiver operating characteristic (TG-ROC) analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00868.X

10.1111/J.1523-5378.2011.00868.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018